Dublin, Oct. 11, 2016 -- Research and Markets has announced the addition of the "Global Oxidative Stress Detection Market 2016-2020" report to their offering.
The global oxidative stress detection market to grow at a CAGR of 9.28% during the period 2016-2020.
The report covers the present scenario and the growth prospects of the global oxidative stress detection market for 2016-2020. To calculate the market size, the report considers the revenue generated by the sales of instruments, reagents, and services provided for oxidative stress detection process. The report also includes a discussion of the key vendors operating in this market.
Over the past decade, a number of new methods that help in detecting, measuring, and studying oxidative stress in live cells have been introduced. ELISA and flow cytometry, along with the relatively newer technologies, are being used to detect oxidative stress in the body, as well as other key vitals and composition details. In the last four years, the trend has shifted from changes in measuring instruments to incremental innovations in the reagents and consumables segment. In 2016, a new salimetrics uric acid assay kit was introduced. It is capable of high-efficiency oxidative stress research, with non-invasive saliva sampling making the process easier and faster. These new methods of detection and the development of new reagents and consumables will open doors to new possibilities of non-invasive detection of oxidative stress in the body.
According to the report, one of the key drivers for market growth will be rapid growth of end-user industries. The primary end-users of oxidative stress assays are the healthcare industry, pharmaceutical industry, and research institutes. The global pharmaceutical industry will grow at a CAGR of 8.8% between 2015 and 2020, with growing investments in drug discovery and detection. Within the pharmaceutical industry, biopharmaceutical and biotechnology sectors are the major users of oxidative stress assays.
The biopharmaceutical sector will grow at a CAGR of 9.8%, followed by biotechnology with 8.6% during the forecast period. Another area of importance for oxidative stress detection is healthcare diagnostics, which has been gaining importance over the past five years and improving its infrastructure since 2010 in most countries. The steady growth of these end-users of oxidative stress assays will drive the demand for these products and solutions during the forecast period.
Key vendors
- Abcam
- EMD Millipore
- Promega
- Qiagen
- Thermo Fisher Scientific
Other prominent vendors
- Amsbio
- Bio-Rad
- BioVision
- Cell Biolabs
- Cell Signaling Technology
- Enzo Biochem
- Genova Diagnostics
- Rel Assay Diagnostics
- Sigma-Aldrich
- tebu-bio
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Market research methodology
Part 04: Introduction
Part 05: Market landscape
Part 06: Market segmentation by product
Part 07: Market segmentation by end-user
Part 08: Geographical segmentation
Part 09: Market drivers
Part 10: Impact of drivers
Part 11: Market challenges
Part 12: Impact of drivers and challenges
Part 13: Market trends
Part 14: Vendor landscape
Part 15: Key vendor analysis
For more information about this report visit http://www.researchandmarkets.com/research/98gvn3/global_oxidative
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biomarkers


Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Italy Fines Apple €98.6 Million Over App Store Dominance
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand 



